For research use only. Not for therapeutic Use.
N-Methyl Palbociclib（Cat No.:I041103）is a modified version of palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). It works by blocking the activity of these kinases, which are crucial for cell cycle progression, particularly in cancer cells. By inhibiting CDK4/6, N-Methyl Palbociclib helps to slow down or stop the proliferation of tumor cells, making it a promising candidate for cancer therapy. Ongoing research aims to evaluate its effectiveness in treating various cancers, including breast cancer, and improve its safety profile in clinical applications.
| CAS Number | 571189-51-0 |
| Synonyms | 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]pyrido[2,3-d]pyrimidin-7-one |
| Molecular Formula | C25H31N7O2 |
| Purity | ≥95% |
| IUPAC Name | 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]pyrido[2,3-d]pyrimidin-7-one |
| InChI | InChI=1S/C25H31N7O2/c1-16-20-15-27-25(28-21-9-8-19(14-26-21)31-12-10-30(3)11-13-31)29-23(20)32(18-6-4-5-7-18)24(34)22(16)17(2)33/h8-9,14-15,18H,4-7,10-13H2,1-3H3,(H,26,27,28,29) |
| InChIKey | PBSZUBKCQUPZFE-UHFFFAOYSA-N |
| SMILES | CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCN(CC4)C)C5CCCC5)C(=O)C |
